Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043955
Filing Date
2021-08-12
Accepted
2021-08-12 16:05:57
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20210630.htm   iXBRL 10-Q 2028038
2 EX-31.1 apvo-ex311_8.htm EX-31.1 20687
3 EX-31.2 apvo-ex312_6.htm EX-31.2 20861
4 EX-32.1 apvo-ex321_11.htm EX-32.1 10175
5 EX-32.2 apvo-ex322_10.htm EX-32.2 10282
  Complete submission text file 0001564590-21-043955.txt   6828778

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA apvo-20210630.xsd EX-101.SCH 51780
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20210630_cal.xml EX-101.CAL 37843
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20210630_def.xml EX-101.DEF 159873
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20210630_lab.xml EX-101.LAB 381909
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20210630_pre.xml EX-101.PRE 289402
11 EXTRACTED XBRL INSTANCE DOCUMENT apvo-10q_20210630_htm.xml XML 1097708
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 211167495
SIC: 2834 Pharmaceutical Preparations